IV-delivered therapy for canine OA advances toward FDA approvalMay 7, 2026A study of intravenous uterine-derived mesenchymal stromal cells (UMSCs) in dogs with “naturally occurring OA” reportedly shows improvements in pain and mobility, with no serious treatment-related adverse events.
SPONSORED CONTENTHill's Prescription Diet Metabolic Weight + j/dNutrition to help mobility in as little as 1 month. 88% of pets lost weight in 2 months at home with Metabolic nutrition. + Learn More